One World One Health: Political and Practical Challenges

9-10 March, 2009, Chatham House, London
A nation's health is no longer its own business. Globalization, increase in population and changes in lifestyle have enabled new infections to emerge and spread rapidly around the world. HIV, SARS and Avian Influenza are but few of the examples - a new disease emerges, on average, every year and at the same time a number of infectious diseases have developed resistance to available treatments. Such problems cannot be managed by nations within their own borders; new directions for global cooperation need to be developed.

This conference will explore global health policy as it intersects with the global political process and propose new ideas for policy and practice in cooperation on global health issues across government departments, between specialist international organisations and between government, the private sector and the NGO community.

Participants from the public and private sectors will bring relevant and current expertise to discuss questions including:

  • How can the divide between donor strategies, national competitiveness and corporate business priorities be bridged?
  • Are there any effective roadmaps for health recovery in post-conflict environments?
  • Are current approaches to domestic security at the border commensurate with the potential health threats?
  • What are the main issues surrounding intellectual property rights and what solutions exist that would support an effective global response to major infectious disease threats such as pandemic influenza?
  • The role and value of innovation: what structures to promote innovation are needed?

For further information and registration, please visit:
http://www.chathamhouse.org.uk/health09

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...